Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,060 | -15,528 | -15,190 | N/A | N/A |
| Depreciation Amortization | 170 | 8 | 8 | N/A | N/A |
| Accounts payable and accrued liabilities | 438 | 214 | 327 | N/A | N/A |
| Other Working Capital | 1,163 | 902 | 1,447 | N/A | N/A |
| Other Operating Activity | -420 | -847 | -594 | 0 | 0 |
| Operating Cash Flow | $-26,709 | $-15,250 | $-14,002 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -4 | N/A | N/A | N/A |
| Investing Cash Flow | $-31 | $-4 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86,977 | 2 | N/A | N/A | N/A |
| Other Financing Activity | 5,598 | 56,365 | 23,344 | 0 | 0 |
| Financing Cash Flow | $92,576 | $56,367 | $23,344 | $N/A | $N/A |
| Exchange Rate Effect | -1,423 | 162 | 1,395 | N/A | N/A |
| Beginning Cash Position | 65,676 | 24,402 | 13,665 | N/A | N/A |
| End Cash Position | 130,089 | 65,676 | 24,402 | N/A | N/A |
| Net Cash Flow | $64,413 | $41,274 | $10,736 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,709 | -15,250 | -14,002 | N/A | N/A |
| Capital Expenditure | -31 | -4 | N/A | N/A | N/A |
| Free Cash Flow | -26,740 | -15,254 | -14,002 | 0 | 0 |